India Glycols Limited will host a plant visit for investors and analysts on September 19 and 20, 2026. The company disclosed the schedule pursuant to Regulation 30 of the SEBI Listing Regulations, aiming to provide stakeholders with an on-ground view of its operations.

Event Schedule

The interaction is structured as a group visit across two days. Participants will tour the company’s manufacturing facilities in Uttarakhand.

Disclosure Details

Ankur Jain, Head (Legal) & Company Secretary, signed the disclosure letter dated September 16, 2026. The company noted that discussions during the visit will be based solely on publicly available information. No unpublished price-sensitive information (UPSI) is intended to be discussed.

India Glycols stated that changes to the meeting schedule may occur due to exigencies on the part of participants or the host. The full disclosure is available on the company’s website.

India Glycols Limited disclosed on September 8, 2026, that Ennature Bio Pharma Limited (EBL) has completed the allotment of equity shares to its shareholders and appointed key managerial personnel. This update addresses observation letters from stock exchanges regarding the ongoing Scheme of Arrangement.

The developments follow EBL’s board meeting on September 8, 2026, which approved the share issuance and new appointments under the merger terms.

Share Allotment

EBL allotted 2,23,42,255 fully paid-up equity shares of ₹5 each to eligible India Glycols shareholders. The allotment was made in a ratio of 1:3 based on the register of members as on the record date of September 2, 2026.

The newly allotted shares rank pari passu with existing equity shares of EBL. The company has approved the Information Memorandum required for listing and trading approval on stock exchanges.

Key Appointments

EBL’s board appointed several key roles to support the transition:

• Ajay Sharma: Appointed as Chief Financial Officer (CFO). He brings over 20 years of experience in pharma and automotive sectors, having been associated with India Glycols since November 2021.
• Preeti Choudhary: Appointed as Company Secretary, Key Managerial Personnel, and Compliance Officer. She is an Associate Member of the Institute of Company Secretaries of India and previously served as CS at Kashipur Holdings Limited.

Auditors and Advisors

The board also approved the appointment of external auditors for the coming financial years:

Previous Director Resignations

This disclosure supplements earlier updates regarding three non-executive directors who resigned from EBL’s board on September 7, 2026, citing personal reasons. The resignations were part of compliance requirements for the Scheme of Arrangement under Sections 230 to 232 of the Companies Act, 2013.

Akshay Bansal, Executive Director of EBL, had confirmed these exits in correspondence with India Glycols. The filings reference SEBI Master Circular No. HO/4911 411 4(7)2025-CFD-POD211 13762/2026 dated January 30, 2026.